Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)

Autor: Choueiri, Toni K., Cheng, Suchun, Qu, Angela Q., Pastorek, Jaromir, Atkins, Michael B., Signoretti, Sabina
Zdroj: In Urologic Oncology: Seminars and Original Investigations November 2013 31(8):1788-1793
Databáze: ScienceDirect
Externí odkaz: